The Story of GLP-1. "A diabetes doctor’s dream". Episode 1

  Рет қаралды 3,483

Novo Nordisk Foundation

Novo Nordisk Foundation

Күн бұрын

Some people eat too much food. Others eat unhealthy food, perhaps because they cannot afford healthy alternatives. Other people continue to eat a balanced diet but still struggle with their weight. How we eat and how our bodies react to food greatly affects our health. More than a third of all deaths today are caused by diseases such as obesity and type 2 diabetes.
But why does the body tell us that it wants more food - even though it has enough energy? And can you get the body to settle for what it needs by adjusting the body’s control systems? These questions have puzzled researchers for decades. And translating new knowledge into something to combat these diseases turned out to be extremely challenging.
In the 1990s, as the obesity pandemic spreads, even young people start to lose their ability to keep their body weight and blood glucose in balance. In turn, researchers and pharmaceutical companies set out to find new remedies.
Follow the Episode 1 "A diabetes doctor’s dream" of this year's Advent Calendar: The Story of GLP-1.
00:00:00 Introduction: Eating Habits and Health
00:00:14 Impact of Obesity and Type 2 Diabetes
00:00:28 Understanding Body's Hunger Signals
00:01:00 Efforts to Combat Obesity in the 1990s
00:01:40 Lotter’s Journey at Novo Nordisk
00:02:00 Challenges Faced by Novo Nordisk in the 1990s
00:02:50 Lotter's Mission and New Leadership
00:03:40 Discovering GLP-1 and Its Potential
00:04:40 Jens Reifeld’s Research Journey
00:05:20 Discovery of GLP-1's Role in Diabetes
00:06:40 Early Clinical Data and Challenges with GLP-1
00:07:30 Turning GLP-1 into a Viable Drug
00:08:10 Overcoming Obstacles and Future Directions

Пікірлер: 6
@VernCrisler
@VernCrisler 10 ай бұрын
I think Lotte and all those involved should receive a Nobel prize in medicine for their development of GLP-1 drugs. As many have said, it's a game changer for diabetes management and obesity management, not to mention possible benefits for heart and neurological health.
@user-vb8qw7fn9t
@user-vb8qw7fn9t 5 ай бұрын
Brilliant! Huge global impact benefiting millions of people worldwide!
@bqwriter
@bqwriter 10 ай бұрын
What an inspiring program, beautifully produced and executed!
@-.-_123
@-.-_123 11 ай бұрын
I'm very thankful for this work. It is really helping me overcome diabetes and I feel great! Much appreciated!❤
@xrang1
@xrang1 Жыл бұрын
Jens Juul Holst is affiliated with the "Department of Biomedical Sciences" and not "biomechanical sciences". That would be an entirely different branch of research not relevant to GLP-1.
@crissya.1932
@crissya.1932 6 ай бұрын
Thank you, Lotte 🥹❤️🙏🙏🙏
The Story of GLP-1."A steak well done”, Episode 3
9:44
Novo Nordisk Foundation
Рет қаралды 2,2 М.
Are There Natural GLP-1 Agonists?
13:15
Dr. Kate Lyzenga-Dean
Рет қаралды 47 М.
터키아이스크림🇹🇷🍦Turkish ice cream #funny #shorts
00:26
Byungari 병아리언니
Рет қаралды 28 МЛН
Tom & Jerry !! 😂😂
00:59
Tibo InShape
Рет қаралды 60 МЛН
THEY WANTED TO TAKE ALL HIS GOODIES 🍫🥤🍟😂
00:17
OKUNJATA
Рет қаралды 12 МЛН
HbA1c Test and What HbA1c Normal Range Means
15:18
Dr. Sten Ekberg
Рет қаралды 775 М.
The Story of GLP-1. "If you don't fix this". Episode 2
9:59
Novo Nordisk Foundation
Рет қаралды 2,4 М.
How to Increase GLP-1 and Lose Weight Naturally
31:53
Rupa Health
Рет қаралды 4,4 М.
My Diagnosis Story | She's Diabetic
18:53
She's Diabetic
Рет қаралды 21 М.
The Story of GLP-1. "The next really good idea". Episode 4
9:59
Novo Nordisk Foundation
Рет қаралды 2,5 М.
Pondering GLP-1 Receptor Agonists for Parkinson’s Disease with Tom Foltynie
1:02:44
BRAIN PONDERINGS podcast with Mark Mattson
Рет қаралды 1,2 М.